CCNB1 and non-small cell lung carcinoma: Recently, increasing evidence demonstrated that CCNB1 was over-expressed in considerable cancers with poor prognosis, including gastric cancer [35], esophageal squamous cell carcinoma [36], non-small cell lung cancer [37] and astrocytomas [38].